Annual Net Margin
10.82%
+16.94%+276.80%
31 December 2023
Summary:
Jazz Pharmaceuticals annual net profit margin is currently 10.82%, with the most recent change of +16.94% (+276.80%) on 31 December 2023. During the last 3 years, it has risen by +0.72% (+7.13%). JAZZ annual net margin is now -78.03% below its all-time high of 49.25%, reached on 31 December 2012.JAZZ Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
20.39%
+3.93%+23.88%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly net profit margin is currently 20.39%, with the most recent change of +3.93% (+23.88%) on 30 September 2024. Over the past year, it has increased by +5.29% (+35.03%). JAZZ quarterly net margin is now -61.68% below its all-time high of 53.21%, reached on 31 December 2017.JAZZ Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +276.8% | +35.0% |
| 3 y3 years | +7.1% | +423.6% |
| 5 y5 years | -54.2% | +7.2% |
JAZZ Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +201.6% | at high | +182.3% |
| 5 y | 5 years | -55.3% | +201.6% | -17.4% | +142.2% |
| alltime | all time | -78.0% | +102.7% | -61.7% | +105.1% |
Jazz Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 20.39%(+23.9%) |
| June 2024 | - | 16.46%(-1116.0%) |
| Mar 2024 | - | -1.62%(-117.4%) |
| Dec 2023 | 10.82%(-276.8%) | 9.30%(-38.4%) |
| Sept 2023 | - | 15.10%(+38.4%) |
| June 2023 | - | 10.91%(+40.2%) |
| Mar 2023 | - | 7.78%(-131.4%) |
| Dec 2022 | -6.12%(-42.5%) | -24.76%(+1084.7%) |
| Sept 2022 | - | -2.09%(-156.2%) |
| June 2022 | - | 3.72%(+1760.0%) |
| Mar 2022 | - | 0.20%(-105.1%) |
| Dec 2021 | -10.65%(-205.4%) | -3.94%(-37.5%) |
| Sept 2021 | - | -6.30%(-87.0%) |
| June 2021 | - | -48.33%(-341.0%) |
| Mar 2021 | - | 20.05%(0.0%) |
| Dec 2020 | 10.10%(-58.3%) | 20.05%(-18.7%) |
| Sept 2020 | - | 24.67%(+20.9%) |
| June 2020 | - | 20.41%(-169.1%) |
| Mar 2020 | - | -29.52%(-332.1%) |
| Dec 2019 | 24.21%(+2.4%) | 12.72%(-33.1%) |
| Sept 2019 | - | 19.02%(-61.2%) |
| June 2019 | - | 49.03%(+192.4%) |
| Mar 2019 | - | 16.77%(-49.9%) |
| Dec 2018 | 23.64%(-21.6%) | 33.47%(+5.2%) |
| Sept 2018 | - | 31.81%(+72.4%) |
| June 2018 | - | 18.45%(+78.4%) |
| Mar 2018 | - | 10.34%(-80.6%) |
| Dec 2017 | 30.14%(+13.0%) | 53.21%(+245.1%) |
| Sept 2017 | - | 15.42%(-42.4%) |
| June 2017 | - | 26.78%(+16.4%) |
| Mar 2017 | - | 23.01%(-21.8%) |
| Dec 2016 | 26.67%(+7.2%) | 29.42%(+22.5%) |
| Sept 2016 | - | 24.01%(-20.1%) |
| June 2016 | - | 30.04%(+33.2%) |
| Mar 2016 | - | 22.56%(-7.1%) |
| Dec 2015 | 24.87%(+399.4%) | 24.28%(-5.9%) |
| Sept 2015 | - | 25.80%(-2.3%) |
| June 2015 | - | 26.40%(+15.5%) |
| Mar 2015 | - | 22.86%(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | 4.98%(-79.9%) | 24.87%(+196.1%) |
| Sept 2014 | - | 8.40%(-44.0%) |
| June 2014 | - | 14.99%(-140.0%) |
| Mar 2014 | - | -37.52%(-260.0%) |
| Dec 2013 | 24.79%(-49.7%) | 23.45%(-27.8%) |
| Sept 2013 | - | 32.48%(+60.3%) |
| June 2013 | - | 20.26%(-8.5%) |
| Mar 2013 | - | 22.13%(+17.0%) |
| Dec 2012 | 49.25%(+7.3%) | - |
| Sept 2012 | - | 18.92%(-13.4%) |
| June 2012 | - | 21.85%(-19.1%) |
| Mar 2012 | - | 27.00%(-39.8%) |
| Dec 2011 | 45.90%(+143.4%) | 44.86%(+1.2%) |
| Sept 2011 | - | 44.32%(-13.8%) |
| June 2011 | - | 51.42%(+19.9%) |
| Mar 2011 | - | 42.90%(-6.4%) |
| Dec 2010 | 18.86%(-454.5%) | 45.83%(+54.9%) |
| Sept 2010 | - | 29.59%(-287.5%) |
| June 2010 | - | -15.78%(-479.3%) |
| Mar 2010 | - | 4.16%(-71.8%) |
| Dec 2009 | -5.32%(-98.1%) | 14.77%(-372.0%) |
| Sept 2009 | - | -5.43%(-193.3%) |
| June 2009 | - | 5.82%(-109.9%) |
| Mar 2009 | - | -58.83%(-79.8%) |
| Dec 2008 | -273.04%(+28.4%) | -290.58%(+79.0%) |
| Sept 2008 | - | -162.34%(-51.4%) |
| June 2008 | - | -333.87%(+4.6%) |
| Mar 2008 | - | -319.19%(-17.7%) |
| Dec 2007 | -212.59%(+60.6%) | -387.80%(+330.2%) |
| Sept 2007 | - | -90.15%(-67.7%) |
| June 2007 | - | -279.47%(+101.0%) |
| Mar 2007 | - | -139.01%(+31.5%) |
| Dec 2006 | -132.40%(-66.7%) | -105.69%(0.0%) |
| Sept 2006 | - | -105.69%(0.0%) |
| June 2006 | - | -105.69%(-53.5%) |
| Mar 2006 | - | -227.50%(-42.7%) |
| Dec 2005 | -397.15% | -397.18%(+0.0%) |
| Sept 2005 | - | -397.11%(0.0%) |
| June 2005 | - | -397.11%(0.0%) |
| Mar 2005 | - | -397.11% |
FAQ
- What is Jazz Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual net margin year-on-year change?
- What is Jazz Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly net margin year-on-year change?
What is Jazz Pharmaceuticals annual net profit margin?
The current annual net margin of JAZZ is 10.82%
What is the all time high annual net margin for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual net profit margin is 49.25%
What is Jazz Pharmaceuticals annual net margin year-on-year change?
Over the past year, JAZZ annual net profit margin has changed by +16.94% (+276.80%)
What is Jazz Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of JAZZ is 20.39%
What is the all time high quarterly net margin for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly net profit margin is 53.21%
What is Jazz Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, JAZZ quarterly net profit margin has changed by +5.29% (+35.03%)